# DOJ

Type: Company

Source: Biotech Intelligence Brief — https://getbiobrief.com/entity/doj-company
Canonical HTML page: https://getbiobrief.com/entity/doj-company

## Timeline

- **2026-03-12**: Missouri Pause Request — DOJ files a request in federal court to pause the Missouri-led lawsuit citing an ongoing FDA review.
- **2026-03-11**: Hawley Federal Bill — Senator Josh Hawley introduces a bill in the Senate to ban mifepristone nationwide.
- **2026-01-15**: Louisiana Pause Request — DOJ asks Louisiana to pause its separate lawsuit; request is rejected by AG Liz Murrill.
- **2025-10-01**: Missouri Lawsuit Filed — Missouri, Kansas, and Idaho file suit against the FDA to restrict mifepristone access.

## Recent coverage (1 stories)

### DOJ Seeks Pause in Missouri Mifepristone Suit Amid FDA Review Strategy
2026-03-13 00:35:09 · Sentiment: Bearish · Impact: 8/10 · Sources: 2

The Department of Justice has requested a federal court to pause a multi-state lawsuit against the FDA regarding the abortion pill mifepristone. The move suggests a strategic effort to allow the FDA to conduct its own internal review of the drug's safety and distribution protocols.
Full story: https://getbiobrief.com/story/doj-missouri-mifepristone-lawsuit-pause

---
This page is a machine-readable summary. Sentiment measures the directional read of each development for this entity, not the tone of the reporting; impact weights consequence, not syndication reach. See https://getbiobrief.com/guides/methodology for the full editorial methodology.